Abstract
The pharmacokinetics of melperone and the relationship between plasma concentration and the effect on arousal and prolactin secretion after single oral doses (10, 25, 50 and 100 mg) was studied in normal subjects. Dose-dependent kinetics were indicated by the fact that higher plasma concentrations than expected were demonstrated after the 100-mg dose. Melperone decreased arousal and increased prolactin secretion in a dose-dependent manner. The level of arousal was correlated to melperone plasma concentration over the entire dose range. Prolactin secretion was also correlated to melperone plasma concentration, provided the relationship was studied separately for the individual melperone doses. Thus at higher doses, higher plasma concentrations are needed to elicit the same prolactin outflow. The possibility that reduced arousal reactions might contribute in the antipsychotic action of neuroleptic drugs was discussed.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Andén NE (1972) Dopamine turnover in the corpus striatum and the limbic system after treatment with neuroleptic and antiacetylcholine drugs. J Pharm Pharmacol 24:905–906
Andén NE, Stock G (1973) Effects of clozapine on the turnover of dopamine in the corpus striatum and the limbic system. J Pharm Pharmacol 25:346–348
Bjerkenstedt L, Eneroth P, Härnryd C, Sedvall G (1977) Effects of melperone and thiothixene on prolactin levels in cerebrospinal fluid and plasma of psychotic women. Arch Psychiatr Nervenkr 224:281–293
Bjerkenstedt L, Härnryd C, Grimm V, Gullberg B, Sedvall G (1978) A double-blind comparison of melperone and thiothixene in psychotic women using a new rating scale, the CPRS. Arch Psychiatr Nervenkr 226:157–172
Borgström L, Larsson H, Molander L (1982) Pharmacokinetics of parenterally and orally administered melperone in man. Eur J Clin Pharmacol 23:173–176
Carlsson C, Gullberg B, Höstery U, Christensson E (1979) A double-blind study of melperone and placebo in hospitalized chronic alcoholics in postintoxication phase. Int J Clin Pharmacol Biopharm 17:341–345
Cohen BM, Herschel U, Aoba A (1979) Neuroleptic antimuscarinic, and antiadrenergic activity of chlorpromazine, thioridazine and their metabolites. Psychiatr Res 1:199–208
Creese I, Snyder SH (1977) A simple and sensitive radioreceptor assay for antischizophrenic drugs in blood. Nature 270:180–182
Farley IJ, Price KS, McCullough E, Deck JHN, Hordynski W, Hornykiewicz O (1978) Norepinephrine in chronic paranoid schizophrenia: Above-normal levels in limbic forebrain. Science 200:456–458
Goldstein MJ, Judd LL, Rodnich EH, Lapolla A (1969) Psychophysiological and behavioural effects of phenothiazine administration in acute schizophrenics as a function of premorbid status. J Psychiatr Res 6:271–287
Gruen PH, Sachar EJ, Langer G, Altman N, Leifer U, Frantz A, Halpern FS (1978) Prolactin responses to neuroleptics in normal and schizophrenic subjects. Arch Gen Psychiatry 35:108–116
Grundström R, Holmberg G, Ledermann H, Livstedt B (1977) Sedative properties of doxepin in comparison with diazepam. Psychopharmacology 54:165–169
Gruyda H (1975) Heterogeneity of human growth hormone and prolactin secretion in vitro: Immunoassay and receptor assay correlations. J Clin Endocrinol Metab 41:953–967
Hacke W, Büssing A, Jungen K (1978) Die Wirkung von Methylperon (Eunerpan) auf aggressives und autoaggressives Verhalten bei Geistigbehinderten — Eine Doppelblindstudie. Pharmacopsychiatr Neuropsychopharmakol 11:86–96
Koch-Weser J (1972) Serum drug concentrations as therapeutic guides. New Engl J Med 287:227–231
Lake CR, Sternberg DE, van Kammen DP, Ballenger JC, Ziegler MG, Post RM, Kopin IJ, Bunney WE (1980) Schizophrenia: Elevated cerebrospinal fluid norepinephrine. Science 207:331–333
Langer G, Sachar EJ, Gruen PH, Halpern FS (1977) Human prolactin responses to neuroleptic drugs correlate with antischizophrenic potency: Nature 266:639–640
Langer G, Sachar EJ, Gruen PH (1978) Prolactin response to neuroleptic drugs in normal and schizophrenic subjects. Psychopharmacol Bull 14:8–9
Meltzer HY, Goode DJ, Fang VS (1978) The effect of psychotropic drugs on endocrine function I. Neuroleptics, precursors and agonists. In: Lipton MA, DiMascio A, Killam KF (eds) Psychopharmacology — a generation of progress. Raven, New York, pp 509–529
Nikitopoulou G, Thorner M, Crammer J, Lader M (1977) Prolactin and psychophysiologic measures after single doses of thioridazine. Clin Pharmacol Ther 21:422–429
Peroutka SJ, U'Prichard DC, Greenberg DA, Snyder SH (1977) Neuroleptic drug interactions with norepinephrine alpha receptor binding sites in rat brain. Neuropharmacology 16:549–556
Peroutka SJ, Snyder SH (1980) Relationship of neuroleptic drug effect at brain dopamine, serotonin, α-adrenergic, and histamine receptors to clinical potency. Am J Psychiatry 137:1518–1522
Pöldinger WJ (1980) Ambulante Erfahrungen mit Melperone bei psychovegetativen Beschwerden unter kontrollierten Bedingungin. Therapiewoche 30:4862–4871
Preissner K, Kinzler K, Lehmann E (1981) Neuroleptische Komedikation in der Gerontopsychiatrie. Therapiewoche 31:8461–8466
Sedvall G, Bjerkenstedt L, Lindström L, Wode-Helgodt B (1978) Clinical assessment of dopamine receptor blockade. Life Sci 23:425–430
Silverman J (1972) Stimulus intensity modulation and psychological disease. Psychopharmacologia 24:42–80
Simonson E, Brozek J (1952) Flicker fusion frequency: Background and applications. Physiol Rev 32:349–378
Smith RC, Crayton JW, Tamminga C, Dekirmenjian H, Schoolar JC, Davis JM (1979) Blood levels of neuroleptic drugs, clinical response, and plasma prolactin in chronic nonresponding schizophrenic patients. In: Schoolar JC, Claghorn JL (eds) The kinetics of psychiatric drugs. Brunner/Mazel Inc., New York, pp 137–170
Snyder SH, Banarjee SP, Yamamura HI, Greenberg D (1974) Drugs, neurotransmitters, and schizophrenia. Science 184:1243–1253
Spohn HE, Lacoursiere RB, Thompson K, Coyne L (1977) Phenothiazine effects on psychological and psychophysiological dysfunction in chronic schizophrenics. Arch Gen Psychiatry 34:633–644
Turkington RW, Underwood LE, van Wyk JJ (1971) Elevated serum prolactin levels after pituitary stalk section in man. New Eng J Med 285:707–710
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Molander, L., Borgström, L. Sedative effects and prolactin response to single oral doses of melperone. Psychopharmacology 79, 142–147 (1983). https://doi.org/10.1007/BF00427801
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00427801